Search Results - "Garrote, M. Rodriguez"

First-line single-agent regorafenib in frail patients with metastatic colorectal cancer: a pilot phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) by Carrato, A, Benavides, M, Massutí, B, Ferreiro-Monteagudo, R, García Alfonso, P, Falcó, E, Reboredo, M, Cano, T, Gallego, J, Viéitez, J M, Layos, L, Salud, A, Polo, E, Dotor, E, Durán-Ogalla, G, Rodriguez-Garrote, M, Calvo, A, Grande, E, Aranda, E

“…Treatment of frail patients with advanced colorectal cancer (CRC) is controversial. This pilot phase II trial aimed to assess the efficacy and safety of…”
Get full text

Locally advanced unresectable or metastatic pancreatic adenocarcinoma in patients under 65 years with good performance status (PS) at Ramón y Cajal University Hospital in Madrid by Martín Huertas, R., Longo Muñoz, F., Serrano Domingo, J., Corral de la Fuente, E., Pachón Olmos, V., Rodriguez Garrote, M., Fuentes, R., Ferreiro Monteagudo, R., Vaz, M., Carrato, A.

Get full text

KRAS negativity and a longer overall survival in hereditary and familial pancreatic cancer cases by Earl, J., Barreto, E., Castillo, M.E., Fuentes, R., Rodriguez-Garrote, M., Ferreiro, R., Reguera, P., Muñoz, G., Garcia-Seisdedos, D., López, J. Villalón, Sainz, B., Malats, N., Carrato, A.

Get full text

FOLFIRINOX versus Nab-paclitaxel plus gemcitabine in the first-line chemotherapy for patients with advanced pancreatic ductal adenocarcinoma: a multivariate analysis of prognostic factors in a national cohort (Comunica-TTD working group) by Longo Muñoz, F., Castillo Trujillo, O., Serrano Domingo, J., Martín Huertas, R., Corral de la Fuente, E., San Juan, A., Portela, J., Cano, J., Reguera Puertas, P., Rodriguez Garrote, M., Izquierdo Manuel, M., Jimenez Fonseca, P., Carrato, A., Aranda, E.

Get full text

Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC) by Argiles, G., Margalef, N. Mulet, Valladares-Ayerbes, M., de Prado, J. Vieitez, Grávalos, C., Alfonso, P. García, Santos, C., Tobeña, M., Sastre, J., Benavides, M., Cano, T., Loupakis, F., Garrote, M. Rodriguez, Rivera, F., Goldberg, R., Falcone, A., Bennouna, J., Ciardiello, F., Tabernero, J., Aranda, E.

Get full text

Impact on survival of local complications in Pancreatic Cancer: experience at the Ramón y Cajal University Hospital (HURyC) by Serrano Domingo, J., Martín Huertas, R., Corral de la Fuente, E., Barquín García, A., Saavedra Serrano, C., Albarrán Artahona, V., Reguera Puertas, P., Fuentes, R., Ferreiro Monteagudo, R., Olmos, V. Pachón, Vaz, M., Villamayor Delgado, M., Rodriguez Garrote, M., Carrato, A., Longo Muñoz, F.

Get full text

Safety and outcomes of self-expandable metal stents (SEMS) versus emergency surgery for acute colonic obstruction in metastatic colon cancer patients treated with bevacizumab (BV) by Pacheco-Barcia, V.E., Mondéjar Solís, R., Martínez-Sáez, O., Longo, F., Bermejo, E., Moreno, J.A., Marin, C., Correa, A., Maqueda, R., Rogado, J., García de Paredes, A., Rodriguez de Santiago, E., Pachón Olmos, V., Ferreiro Monteagudo, R., Rodriguez Garrote, M., Carrato Mena, A., Donnay, O., Martin Perez, E., Santander, C., Colomer Bosch, R.

Get full text

Safety of self-expandable metal stents (SEMS) or emergency surgery for acute colonic obstruction in metastatic colon cancer patients treated with bevacizumab by Pacheco-Barcia, V., Solís, R. Mondéjar, Saez, O. Martínez, Muñoz, F. Longo, Bermejo, E., Monteagudo, J. Moreno, Marin, C., Correa, A., Maqueda, R., Rogado, J., de Paredes, A. Garcia, de Santiago, E. Rodriguez, Olmos, V. Pachón, Monteagudo, R. Ferreiro, Garrote, M. Rodriguez, Carrato, A., Donnay, O., Martin, E., Santander, C., Colomer, R.

Get full text

Analysis of global factors associated with survival in esophageal squamous cell carcinoma: Our experience at Ramon y Cajal Hospital by García, A. Barquín, Domingo, J. Serrano, Serrano, C. Saavedra, Artahona, V. Albarrán, Delgado, M. Villamayor, Saez, O. Martínez, Cerrillo, J. Molina, Huertas, R. Martín, de la Fuente, E. Corral, Monteagudo, R. Ferreiro, Garrote, M. Rodriguez, Olmos, V. Pachón, Vaz, M., Puertas, P. Reguera, Guillén-Ponce, C., Carrato, A., Muñoz, F. Longo

Get full text

Analysis of classical high risk factors in stage III colon cancer: Experience at University Hospital Ramon y Cajal (UHRyC) by Domingo, J. Serrano, Huertas, R. Martín, García, A. Barquín, de la Fuente, E. Corral, Serrano, C. Saavedra, Delgado, M. Villamayor, Saez, O. Martínez, Muñoz, F. Longo, Olmos, V Pachón, Garrote, M. Rodriguez, Vaz, M., Puertas, P Reguera, Fuentes, R., Carrato, A., Monteagudo, R. Ferreiro

Get full text

Efficacy of adjuvant chemotherapy for elderly patients with colon cancer by Delgado, M. Villamayor, Serrano, C. Saavedra, de la Fuente, E. Corral, García, A. Barquín, Saez, O. Martínez, Huertas, R. Martín, Domingo, J. Serrano, Cerrillo, J. Molina, Muñoz, F. Longo, Olmos, V. Pachón, Garrote, M. Rodriguez, Puertas, P. Reguera, Vaz, M., Carrato, A., Monteagudo, R. Ferreiro

Get full text

Predictive factors for early relapse and survival in resected pancreatic cancer: A single institution experience by Serrano, C. Saavedra, Puertas, P. Reguera, Saez, O. Martínez, Muñoz, F. Longo, García, A. Barquín, Artahona, V. Albarrán, Delgado, M. Villamayor, Cerrillo, J. Molina, de la Fuente, E. Corral, Huertas, R. Martín, Domingo, J. Serrano, Olmos, V. Pachón, Monteagudo, R. Ferreiro, Garrote, M. Rodriguez, Vaz, M., Fuentes, R., Guillén-Ponce, C., Carrato, A.

Get full text

Analysis of the benefit of the adjuvant chemotherapy in stage II colon cancer according to the presence of classic poor risk factors: Our experience in Ramon y Cajal Hospital by Serrano, C. Saavedra, Delgado, M. Villamayor, de la Fuente, E. Corral, García, A. Barquín, Domingo, J. Serrano, Huertas, R. Martín, Saez, O. Martínez, Muñoz, F. Longo, Puertas, P. Reguera, Olmos, V. Pachón, Garrote, M. Rodriguez, Vaz, M., Fuentes, R., Carrato, A., Monteagudo, R Ferreiro

Get full text

Benefit of the addition of oxaliplatin to 5-FU/leucovorin or capecitabine in adjuvant therapy for stage II/III colorectal cancer in elderly patients: Experience in Ramon y Cajal University Hospital by de la Fuente, E. Corral, Serrano, C. Saavedra, Delgado, M. Villamayor, García, A. Barquín, Huertas, R. Martín, Domingo, J. Serrano, Saez, O. Martínez, Olmos, V. Pachón, Garrote, M. Rodriguez, Muñoz, F. Longo, Puertas, P. Reguera, Guillén-Ponce, C., Carrato, A., Monteagudo, R. Ferreiro

Get full text

Impact of adding oxaliplatin to fluoropyrimidines in the adjuvant therapy in stage II in colon cancer: Experience in Ramon y Cajal Universitary Hospital by Huertas, R. Martín, Domingo, J. Serrano, de la Fuente, E. Corral, García, A. Barquín, Delgado, M. Villamayor, Serrano, C. Saavedra, Saez, O. Martínez, Muñoz, F. Longo, Olmos, V. Pachón, Garrote, M. Rodriguez, Vaz, M., Carrato, A., Puertas, P. Reguera, Fuentes, R., Monteagudo, R. Ferreiro

Get full text

P-016Circulating mRNA expression of CD133, SNAIL, ZEB1 and ZHX as biomarkers in gastric and esophageal cancer by Longo Munoz, F, Earl, J, Martinez Avila, J, Rodriguez Garrote, M, Guerrero, C, Galindo, J, Priego, P, Rodriguez, G, Garcia-Moreno, F, Lopez, F, Hervas, A, Caminoa, A, Garcia, I, Soteras, C, Vazquez-Sequeiros, E, Botella, J, Pachon Olmos, V, Ferreiro Monteagudo, R, Vaz, M, Gomez, A, Guillen-Ponce, C, Carrato, A

Get full text

Characterization of the germline and somatic mutation profile in familial pancreatic cancer reveals pathogenic germline variants and potentially druggable somatic mutations by Earl, J., Castillo, M., Barreto, E., Rodríguez-Garrote, M., Pachón, V., Ferreiro, R., Villamayor, M., Malats, N., Muñoz, G., Carrato, A.

Get full text

428 KRAS mutant circulating free DNA (cfDNA) and circulating tumor cell (CTC) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer by Earl, J, Garcia-Nieto, S, Martinez-Avila, J.C, Montans, J, Sanjuanbenito, A, Rodríguez-Garrote, M, Lisa, E, Mendia, E, Lobo, E, Malats, N, Carrato, A, Guillen, C

Get full text

P-192 Real-world experience with trifluridine/tipiracil on metastatic colorectal cancer in a third level hospital by Rodríguez, D. Rosero, Perez de Aguado, P., Perez, J. Chamorro, Fernandez, V. Albarrán, Longo, F., Puertas, P. Reguera, Delfrade, M., Mateos, R. Fuentes, Guillén-Ponce, C., Gómez, V. López, Garrote, M. Rodriguez, Vaz, M., Delgado, M. Villamayor, Fradejas, J. Fernandez, Garrido, P., Gil, M., Pozas, J., López, E. Gemeno, Rubio, P. Sotoca, Navarro, V. Alía, Corpa, A. Barrill, Monteagudo, R. Ferreiro

Get full text

P-175 Next-generation sequencing in colorectal cancer patients: Characterization and prognostic implications by Longo, F., Pozas, J., Puertas, P. Reguera, Delfrade, M., Corpa, A. Barrill, Calvo, J., Mateos, R. Fuentes, Guillén-Ponce, C., Garrote, M. Rodriguez, Gómez, V. López, Domingo, J. Serrano, Vaz, M., Delgado, M. Villamayor, Lario, M., Santón, A., Ferrer, A., Ruz, I., Caminoa, A., Perna, L., Palacios, J., Garrido, P., Monteagudo, R. Ferreiro

Get full text